Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,665 across all filing types
Latest filing 2018-08-08 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Distribution agreement renewed for infusion supply chain 2 pages 32.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Admedus Limited about the renewal of a distribution agreement with Summit Medical Products Inc. It is a straightforward corporate announcement regarding a business arrangement renewal, with no financial statements, regulatory certifications, or detailed financial data. The document length is short (2905 characters), and it does not mention any report publication or filing of financial results. It is not a report, transcript, or regulatory filing but a business update. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and miscellaneous filings that do not fit other specific categories.
2018-08-08 English
Extension of Voluntary Suspension 1 page 222.4KB
Capital/Financing Update Classification · 95% confidence The document is a letter from the company to the ASX (Australian Securities Exchange) requesting an extension of a voluntary suspension of trading in its shares. It references a previous trading halt request and discusses the need for suspension to finalize negotiations related to a capital raising (placement). The document is short (1706 characters) and is an announcement about a trading suspension related to capital raising activities, not a financial report or detailed update. It does not contain financial statements or detailed financial data. Therefore, it is best classified as a Capital/Financing Update (CAP).
2018-08-07 English
Voluntary Suspension 2 pages 284.1KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Admedus Limited regarding a voluntary suspension of its securities from official quotation on the ASX. It references Listing Rule 17.2 and explains the suspension is pending the release of an announcement about a capital raising placement. The document is short (2461 characters) and primarily serves as a notification of the suspension event, not a detailed financial report or capital raising update itself. It does not contain financial statements or substantive financial data, nor is it a full capital/financing update report. This fits the definition of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2018-08-05 English
Trading Halt 2 pages 652.2KB
Capital/Financing Update Classification · 90% confidence The document is a market announcement from Admedus Limited dated 2 August 2018, requesting a trading halt pending the release of an announcement regarding a capital raising. It is a short notice about the trading halt and does not contain any financial data, detailed report, or analysis. It is an announcement related to capital raising but does not provide the actual update or details of the capital raising itself. According to the rules, such a document is best classified as a Capital/Financing Update (CAP) because it relates to financing activities and capital structure changes, even though it is a preliminary notice rather than the full update. The document is not a full report, not a regulatory filing, and not a report publication announcement. Therefore, the best fit is CAP with high confidence.
2018-08-01 English
Appendix 4C - quarterly 9 pages 281.2KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'QUARTERLY REPORT – APPENDIX 4C FOR THE PERIOD TO 30 JUNE 2018' and contains detailed financial and operational information for the quarter ending June 30, 2018. It includes cash flow statements, revenue highlights, corporate activities, and strategic updates. The presence of an Appendix 4C quarterly cash flow report and detailed quarterly financial data indicates this is a comprehensive interim financial report for a period shorter than a full fiscal year. The document is about 15,000 characters long, which is substantial and contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q4 2018
2018-07-30 English
Major Milestone for TAVR As Trials Commence 2 pages 625.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Admedus Limited about a major milestone in their Transcatheter Aortic Valve Replacement (TAVR) project, specifically the commencement of animal trials and the first successful live implantation of their valve. The content focuses on R&D progress and clinical development updates rather than financial results, management changes, or regulatory filings. The document is relatively short (4107 characters) and does not contain financial statements or detailed financial data. It is an announcement of a development milestone rather than a report or detailed presentation. Therefore, it fits best under the category of a general regulatory announcement or company update that does not fit other specific categories, which corresponds to Regulatory Filings (RNS).
2018-07-10 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.